Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 7592

Hubble Finds That Betelgeuse’s Mysterious Dimming Is Due to a Traumatic Outburst

Observations by NASA ’s Hubble Space Telescope are showing that the unexpected dimming of the supergiant star Betelgeuse was most likely caused by an immense amount of hot material ejected into space, forming a dust cloud that blocked starlight coming from Betelgeuse’s surface.

Hubble researchers suggest that the dust cloud formed when superhot plasma unleashed from an upwelling of a large convection cell on the star’s surface passed through the hot atmosphere to the colder outer layers, where it cooled and formed dust grains. The resulting dust cloud blocked light from about a quarter of the star’s surface, beginning in late 2019. By April 2020, the star returned to normal brightness.

Read more | >

Betelgeuse has been the center of significant media attention lately. The red supergiant is nearing the end of its life, and when a star over 10 times the mass of the Sun dies, it goes out in spectacular fashion. With its brightness recently dipping to the lowest point in the last hundred years, many space enthusiasts are excited that Betelgeuse may soon go supernova, exploding in a dazzling display that could be visible even in daylight.

While the famous star in Orion’s shoulder will likely meet its demise within the next million years — practically couple days in cosmic time — scientists maintain that its dimming is due to the star pulsating. The phenomenon is relatively common among red supergiants, and Betelgeuse has been known for decades to be in this group.

Coincidentally, researchers at UC Santa Barbara have already made predictions about the brightness of the supernova that would result when a pulsating star like Betelgeuse explodes.

Read more | >

If we can harness it, quantum technology promises fantastic new possibilities. But first, scientists need to coax quantum systems to stay yoked for longer than a few millionths of a second.

A team of scientists at the University of Chicago’s Pritzker School of Molecular Engineering announced the discovery of a simple modification that allows to stay operational—or “coherent”—10,000 times longer than before. Though the scientists tested their technique on a particular class of quantum systems called solid-state qubits, they think it should be applicable to many other kinds of quantum systems and could thus revolutionize quantum communication, computing and sensing.

The study was published Aug. 13 in Science.

Read more | >

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes severe respiratory tract infections in humans (COVID-19), has become a global health concern. Currently, several vaccine candidates against SARS-CoV-2 are in clinical trials but approval of these vaccines is likely to take a long time before they are available for public use. In a previous report, the importance of passive immunity and how immunoglobulin (Ig)G collected from recovered coronavirus patients could help in the protection against COVID-19 and boost the immune system of new patients was reported. Passive immunity by immunoglobulin transfer is a concept employed by most mammals and bovine IgG has a role to play in human therapy. IgG is one of the major components of the immunological activity found in cow’s milk and colostrum. Heterologous transfer of passive immunity associated with the consumption of bovine immune milk by humans has been investigated for decades for its immunological activity against infections. This short review focuses on passive immunity and how microfiltered raw immune milk or colostrum collected from cows vaccinated against SARS-CoV-2 could provide short-term protection against SARS-CoV-2 infection in humans and could be used as an option until a vaccine becomes commercially available.

Currently, different academic institutions and pharmaceutical companies worldwide have started programs to develop and test vaccine candidates against SARS-CoV-2 in clinical trials. An S-glycoprotein-based vaccine is a promising approach that has attracted the attention of scientists, since S-glycoprotein can be directly recognized by the host’s immune system. For the first coronavirus (SARS-CoV-1), which was identified in Guangdong province, China, in November 2002, different vaccines were developed and tested in animal models. Some of these vaccines prevented animal infection after challenge with SARS-CoV-1. Kapadia et al. showed that neutralizing antibodies against SARS-CoV-1 could be detected in sera from mice immunized with S-glycoprotein of SARS-CoV-1 (10, 11).

Read more | >

Everybody has questions about space and what’s beyond the horizon. Our mission is to be the answer.

Welcome to the United States Air Force. Learn about great opportunities for enlisted airmen, officers and health care professionals.

Read more | >